Problems for Big Pharma
USA Today reports:
Rest of Article
WASHINGTON (AP) — The Justice Department is accusing Abbott Laboratories of vastly inflating prices of its drugs as part of a fraudulent billing scheme alleged to have cost government health programs more than $175 million over 10 years.And this is supposed to surprise us?
Abbott bumped up the reported price of the intravenous antibiotic vancomycin as much as 18 times what it charged health care providers, knowing that the Medicare and Medicaid programs would reimburse the providers based on the manufacturer's price, according to a whistle-blower lawsuit unsealed Thursday.
Abbott, based in North Chicago, Ill., participated in such a billing scheme because hospitals, pharmacies and other providers would get to pocket the difference and would be more likely to prescribe the company's products again, the Justice Department contended.
Other Abbott water-based solutions used in administering IV drugs and to replace fluids in the body also were part of the arrangement, the department said.
Rest of Article